Areas of Focus
- Targeted New Drug Development
- Development of New Medical Devices
Work Experience
- 2015.12-present: Researcher and Doctoral Supervisor at the Institute of Life Medical Sciences, East China Normal University
- 2010.1-2015.12: Associate Professor at the Institute of Life Medical Sciences, East China Normal University
- 2007.7-2009.12: Lecturer at the Institute of Life Medical Sciences, East China Normal University
Academic Background & Achievements
- Ph.D. in Joint Training Program, Texas A&M University and East China Normal University (2005.11-2007.6)
- Ph.D. studies at East China Normal University, School of Life Sciences (2004.6-2005.11)
- Master's degree from Hunan Normal University, School of Life Sciences (2001.9-2004.6)
Publications
- Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment, Zhengfang Yi*, Mingyao Liu*, 2024
- Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4, Zhengfang Yi*, Shihong Peng*, 2024
Awards
- 2021.11 International Entrepreneur Coach (Intermediate) (Certificate No. IEC138031-M-CH)
- 2021.12 Expert Judge at the National Postdoctoral First Innovation and Entrepreneurship Competition